Taken together, results from vesicle motility assays indicate that pathogenic forms of two seemingly different ALS-linked proteins (FUS and SOD1) converge on a common pathway that involves aberrant activation of p38-specific MAP kinase pathways. Here, FUS is linked to amyotrophic lateral sclerosis.